Micro Emerging Active

ウエスト・ファーマシューティカル CEO 交代

カバレッジが限定的な新しいナラティブ — まだ形成中です。

スコア
0.2
勢い
▲ 0.0
記事
4
情報源
2

値上がり・値下がり上位

ティッカーセクター変動
XLV
—+4.8%

センチメントタイムライン

イベントタイムライン

4月 01, 2026
Here's What to Expect From West Pharmaceutical's Next Earnings Report Neutral
3月 28, 2026
Is West Pharmaceutical Services, Inc. (WST) A Good Stock To Buy Now? Bullish
3月 27, 2026
West Pharmaceutical CEO Plans Exit after 11 Years, Succession Process Underway Neutral

仮説

Pending 期日: 2026年7月25日

West Pharmaceutical's Q3 2024 revenue guidance will be maintained or increased (no downward revision) despite CEO transition, with management affirming full-year 2024 outlook, demonstrating operational stability.

Pending 期日: 2026年6月25日

If West Pharmaceutical announces an internal successor within 60 days of CEO exit announcement, WST stock will recover and trade at or above pre-announcement levels by day 90, indicating market confidence in continuity.

Pending 期日: 2026年4月6日

West Pharmaceutical Services (WST) stock will experience a negative price reaction of 3-5% within 5 trading days following the CEO exit announcement due to succession uncertainty and potential disruption to strategic initiatives.

関連記事

Here's What to Expect From West Pharmaceutical's Next Earnings Report

Yahoo Finance · 4月 01, 2026
Mixed

タイムライン

初回検出3月 27, 2026
最終更新3月 27, 2026